{
    "SPADE_UN_25317": {
        "Sequence Information": {
            "Peptide Name": "So_ce_56_913",
            "Sequence": "VEKSEKAISGARRGSPIVNRHVVHLEHVRLKGPYRLSDRLSSAPRTSTRV",
            "Sequence Length": 50,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antibiofilm"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "In Silico and In Vitro Analyses Reveal Promising Antimicrobial Peptides from Myxobacteria.",
                    "Pubmed ID": "36586039",
                    "Reference": "Probiotics Antimicrob Proteins. 2023;15:202-214",
                    "Author": "Arakal BS, Whitworth DE, James PE, Rowlands R, Madhusoodanan NPT, Baijoo MR, Livingstone PG",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/36586039"
                }
            ],
            "Mass": 5604.35,
            "PI": 11.55,
            "Net Charge": 10,
            "Hydrophobicity": -0.69,
            "Frequent Amino Acids": "RSV",
            "Absent Amino Acids": "CFMOQUW",
            "Basic Residues": 14,
            "Acidic Residues": 4,
            "Hydrophobic Residues": 15,
            "Polar Residues": 35,
            "Positive Residues": 14,
            "Negative Residues": 4,
            "SPADE ID": "SPADE_UN_25317",
            "Similar Sequences": [],
            "Hemolytic Activity": "",
            "Target Organism": "Escherichia coli ATCC 25922(MIC=250µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=>500µg/ml),Klebsiella pneumoniae ATCC 13883(MIC=>500µg/ml),Staphylococcus aureus ATCC 25923(MIC=>500µg/ml),Bacillus subtilis(MIC=250µg/ml)"
        }
    }
}